LOVE — Cannara Biotech Balance Sheet
0.000.00%
Last trade - 00:00
- CA$75.62m
- CA$121.63m
- CA$57.56m
- 43
- 94
- 35
- 58
2019 August 31st | 2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 August 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 26.5 | 7.77 | 8.16 | 12.1 | 4.27 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.828 | 0.309 | 2.97 | 8.62 | 10.6 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 27.8 | 10.5 | 19.2 | 41 | 51.7 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 39.3 | 43.6 | 71.7 | 83.4 | 89.4 |
Net Intangible Assets | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 68.1 | 54.9 | 92 | 126 | 142 |
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 5.09 | 3.48 | 6.83 | 11.9 | 21.2 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 20.9 | 16.5 | 27.9 | 58.9 | 61.8 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 47.2 | 38.4 | 64.1 | 66.7 | 79.7 |
Total Liabilities & Shareholders' Equity | 68.1 | 54.9 | 92 | 126 | 142 |
Total Common Shares Outstanding |